Avid Bioservices Inc’s filing revealed that its Chief Commercial Officer Kwietniak Matthew R. unloaded Company’s shares for reported $1855.0 on Jan 12 ’24. In the deal valued at $6.77 per share,274 shares were sold. As a result of this transaction, Kwietniak Matthew R. now holds 19,829 shares worth roughly $0.13 million.
Then, Hart Daniel R sold 2,408 shares, generating $14,857 in total proceeds. Upon selling the shares at $6.17, the Chief Financial Officer now owns 79,305 shares.
Before that, Ziebell Mark R sold 1,346 shares. Avid Bioservices Inc shares valued at $8,305 were divested by the V. P., General Counsel at a price of $6.17 per share. As a result of the transaction, Ziebell Mark R now holds 63,269 shares, worth roughly $0.43 million.
William Blair initiated its Avid Bioservices Inc [CDMO] rating to a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who increased its forecast for the stock in mid March from “a Sector weight” to “an Overweight”. KeyBanc Capital Markets also remained covering CDMO and has decreased its forecast on December 08, 2021 with a “Sector weight” recommendation from previously “an Overweight” rating. RBC Capital Mkts started covering the stock on March 17, 2021. It rated CDMO as “an Outperform”.
Price Performance Review of CDMO
On Friday, Avid Bioservices Inc [NASDAQ:CDMO] saw its stock fall -2.32% to $6.74. Over the last five days, the stock has gained 6.31%. Avid Bioservices Inc shares have risen nearly 3.69% since the year began. Nevertheless, the stocks have fallen -66.50% over the past one year. While a 52-week high of $21.05 was reached on 03/06/24, a 52-week low of $4.07 was recorded on 01/05/24. SMA at 50 days reached $7.00, while 200 days put it at $8.45. A total of 0.79 million shares were traded, compared to the trading of 0.63 million shares in the previous session.
Levels Of Support And Resistance For CDMO Stock
The 24-hour chart illustrates a support level at 6.58, which if violated will result in even more drops to 6.42. On the upside, there is a resistance level at 6.93. A further resistance level may holdings at 7.12. The Relative Strength Index (RSI) on the 14-day chart is 48.99, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.66%. Stochastics %K at 63.68% indicates the stock is a holding.
The most recent change occurred on November 10, 2020 when KeyBanc Capital Markets began covering the stock and recommended ‘”an Overweight”‘ rating along with a $12 price target.
